Literature DB >> 23391959

Phenibut dependence.

Andriy V Samokhvalov1, C Lindsay Paton-Gay, Kam Balchand, Jürgen Rehm.   

Abstract

Phenibut is a γ-aminobutyric acid (GABA) agonist designed and used as an anxiolytic in Russia. In Western countries, phenibut is not a registered medication but is available through online stores as a supplement. We present a case of a patient who used phenibut to self-medicate anxiety, insomnia and cravings for alcohol. While phenibut was helpful initially, the patient developed dependence including tolerance, significant withdrawal symptoms within 3-4 h of last use and failure to fulfil his roles at work and at home. He finally sought medical assistance in our addictions clinic. We have gradually, over the course of 9 weeks, substituted phenibut with baclofen, which has similar pharmacological properties, and then successfully tapered the patient off baclofen. This required approximately 10 mg of baclofen for each gram of phenibut.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391959      PMCID: PMC3604470          DOI: 10.1136/bcr-2012-008381

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Withdrawal symptoms after Internet purchase of phenibut (β-phenyl-γ-aminobutyric acid HCl).

Authors:  Rhanda Marie M Magsalin; Ahsan Y Khan
Journal:  J Clin Psychopharmacol       Date:  2010-10       Impact factor: 3.153

2.  "Legal highs" on the net-Evaluation of UK-based Websites, products and product information.

Authors:  Martin M Schmidt; Akhilesh Sharma; Fabrizio Schifano; Charlotte Feinmann
Journal:  Forensic Sci Int       Date:  2010-07-21       Impact factor: 2.395

3.  EU drug monitoring agency voices concerns over "legal highs".

Authors:  Rory Watson
Journal:  BMJ       Date:  2010-11-12

4.  Benzodiazepine withdrawal: an unfinished story.

Authors:  H Ashton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

Review 5.  Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug.

Authors:  I Lapin
Journal:  CNS Drug Rev       Date:  2001

Review 6.  Opioid receptors and legal highs: Salvia divinorum and Kratom.

Authors:  Kavita M Babu; Christopher R McCurdy; Edward W Boyer
Journal:  Clin Toxicol (Phila)       Date:  2008-02       Impact factor: 4.467

  6 in total
  7 in total

Review 1.  Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.

Authors:  Matthew I Hardman; Juraj Sprung; Toby N Weingarten
Journal:  Bosn J Basic Med Sci       Date:  2019-05-20       Impact factor: 3.363

2.  Dissociative Intoxication and Prolonged Withdrawal Associated With Phenibut: A Case Report.

Authors:  Yash B Joshi; Samantha F Friend; Berenice Jimenez; Louisa R Steiger
Journal:  J Clin Psychopharmacol       Date:  2017-08       Impact factor: 3.153

3.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

Review 4.  Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction.

Authors:  Edward A Jouney
Journal:  Curr Psychiatry Rep       Date:  2019-03-09       Impact factor: 5.285

5.  The Psychonauts' World of Cognitive Enhancers.

Authors:  Flavia Napoletano; Fabrizio Schifano; John Martin Corkery; Amira Guirguis; Davide Arillotta; Caroline Zangani; Alessandro Vento
Journal:  Front Psychiatry       Date:  2020-09-11       Impact factor: 4.157

6.  When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use.

Authors:  Kirsten E Smith; Jeffery M Rogers; Justin C Strickland; David H Epstein
Journal:  Am J Drug Alcohol Abuse       Date:  2021-04-28       Impact factor: 3.912

7.  Phenibut Addiction in a Patient with Substance Use Disorder.

Authors:  Kan Hong Zheng; Afra Khan; Eduardo D Espiridion
Journal:  Cureus       Date:  2019-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.